Search Results

There are 8340565 results for: content related to: Mydriasis in a Parkinson disease patient on low-dose carbidopa/levodopa

  1. You have free access to this content
    Carbidopa abrogates L-dopa decarboxylase coactivation of the androgen receptor and delays prostate tumor progression

    International Journal of Cancer

    Volume 130, Issue 12, 15 June 2012, Pages: 2835–2844, Latif A. Wafa, Helen Cheng, Nathan Plaa, Fariba Ghaidi, Takahiro Fukumoto, Ladan Fazli, Martin E. Gleave, Michael E. Cox and Paul S. Rennie

    Version of Record online : 14 SEP 2011, DOI: 10.1002/ijc.26287

  2. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 29, Issue S1, May 2014, Pages: S1–S571,

    Version of Record online : 6 JUN 2014, DOI: 10.1002/mds.25914

  3. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 27, Issue S1, June 2012, Pages: S1–S523,

    Version of Record online : 19 JUN 2012, DOI: 10.1002/mds.25051

  4. You have free access to this content
    Poster Session

    Movement Disorders

    Volume 31, Issue S2, June 2016, Pages: S1–S697,

    Version of Record online : 19 JUN 2016, DOI: 10.1002/mds.26688

  5. You have free access to this content
    Poster Presentations

    Movement Disorders

    Volume 30, Issue S1, June 2015, Pages: S1–S567,

    Version of Record online : 12 JUN 2015, DOI: 10.1002/mds.26295

  6. Carbidopa enhances antitumoral activity of bicalutamide on the androgen receptor-axis in castration-resistant prostate tumors

    The Prostate

    Volume 72, Issue 8, 1 June 2012, Pages: 875–885, Christian Thomas, Latif A. Wafa, Francois Lamoureux, Helen Cheng, Ladan Fazli, Martin E. Gleave and Paul S. Rennie

    Version of Record online : 5 OCT 2011, DOI: 10.1002/pros.21490

  7. You have free access to this content
    Abstracts

    Movement Disorders

    Volume 32, Issue S2, June 2017, Pages: S1–S627,

    Version of Record online : 2 JUN 2017, DOI: 10.1002/mds.27087

  8. Twenty Sixth Annual Symposium on Etiology, Pathogenesis, and Treatment of Parkinson Disease and Other Movement Disorders

    Movement Disorders

    Volume 27, Issue 4, April 2012, Pages: e1–e13,

    Version of Record online : 4 APR 2012, DOI: 10.1002/mds.24987

  9. Are high doses of carbidopa a concern? A randomized, clinical trial in Parkinson's disease

    Movement Disorders

    Volume 27, Issue 6, May 2012, Pages: 750–753, Lissa S. Brod, Jason L. Aldred and John G. Nutt

    Version of Record online : 16 APR 2012, DOI: 10.1002/mds.24998

  10. You have free access to this content
    Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses

    British Journal of Clinical Pharmacology

    Volume 58, Issue s1, November 2004, Pages: 41–49, Chukwuemeka S. Okereke, Louis Kirby, Dinesh Kumar, Edward I. Cullen, Raymond D. Pratt and William A. Hahne

    Version of Record online : 20 OCT 2004, DOI: 10.1111/j.1365-2125.2004.01799.x

  11. Lack of Pharmacokinetic Interactions Between Transdermal Rotigotine and Oral Levodopa/Carbidopa

    The Journal of Clinical Pharmacology

    Volume 49, Issue 9, September 2009, Pages: 1047–1055, Marina Braun, Willi Cawello, Jens-Otto Andreas, Dipl Math, Hilmar Boekens and Rolf Horstmann

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009338481

  12. Double-blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease

    Movement Disorders

    Volume 29, Issue 1, January 2014, Pages: 75–82, Peter A. LeWitt, F. Jacob Huff, Robert A. Hauser, Dan Chen, Dmitri Lissin, Katie Zomorodi and Kenneth C. Cundy

    Version of Record online : 13 DEC 2013, DOI: 10.1002/mds.25742

  13. Levodopa-entacapone-carbidopa intestinal gel in Parkinson's disease: A randomized crossover study

    Movement Disorders

    Volume 32, Issue 2, February 2017, Pages: 283–286, Marina Senek, Elisabet I. Nielsen and Dag Nyholm

    Version of Record online : 17 DEC 2016, DOI: 10.1002/mds.26855

  14. Novel formulations and modes of delivery of levodopa

    Movement Disorders

    Volume 30, Issue 1, January 2015, Pages: 114–120, Werner Poewe and Angelo Antonini

    Version of Record online : 5 DEC 2014, DOI: 10.1002/mds.26078

  15. Pharmacokinetics of Levodopa/Carbidopa Delivered From Gastric-Retentive Extended-Release Formulations in Patients With Parkinson's Disease

    The Journal of Clinical Pharmacology

    Volume 52, Issue 7, July 2012, Pages: 1069–1077, Cuiping Chen, Verne E. Cowles, Mike Sweeney, Igor D. Stolyarov and Sergey N. Illarioshkin

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011409232

  16. You have free access to this content
    Entacapone improves the availability of l-dopa in plasma by decreasing its peripheral metabolism independent of l-dopa/carbidopa dose

    British Journal of Clinical Pharmacology

    Volume 54, Issue 4, October 2002, Pages: 363–371, Helena Heikkinen, Anu Varhe, Tarmo Laine, Jaakko Puttonen, Marjo Kela, Seppo Kaakkola and Kari Reinikainen

    Version of Record online : 23 OCT 2002, DOI: 10.1046/j.1365-2125.2002.01654.x

  17. Levodopa infusion does not decrease the onset of abnormal involuntary movements in parkinsonian rats

    Movement Disorders

    Volume 28, Issue 8, July 2013, Pages: 1072–1079, Maria Papathanou, Rika van der Laan, Peter Jenner, Sarah Rose and Andrew C. McCreary

    Version of Record online : 2 NOV 2012, DOI: 10.1002/mds.25218

  18. You have free access to this content
    COMT inhibition with tolcapone does not affect carbidopa pharmacokinetics in parkinsonian patients in levodopa/carbidopa (Sinemet®)

    British Journal of Clinical Pharmacology

    Volume 48, Issue 3, September 1999, Pages: 449–452, Karin M. Jorga and David J. Nicholl

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2125.1999.00027.x

  19. You have full text access to this OnlineOpen article
    Effect of levodopa-carbidopa intestinal gel on dyskinesia in advanced Parkinson's disease patients

    Movement Disorders

    Volume 31, Issue 4, April 2016, Pages: 530–537, Angelo Antonini, Victor S. C. Fung, James T. Boyd, John T. Slevin, Coleen Hall, Krai Chatamra, Susan Eaton and Janet A. Benesh

    Version of Record online : 28 JAN 2016, DOI: 10.1002/mds.26528

  20. New treatments for levodopa-induced motor complications

    Movement Disorders

    Volume 30, Issue 11, 15 September 2015, Pages: 1451–1460, Olivier Rascol, Santiago Perez-Lloret and Joaquim J Ferreira

    Version of Record online : 21 AUG 2015, DOI: 10.1002/mds.26362